Works matching IS 15588211 AND DT 2021 AND VI 16 AND IP 5

Results: 13

Elevating Twitter-Based Journal Club Discussions by Leveraging a Voice-Based Platform: #HemepathJC Meets Clubhouse.

Published in:

Current Hematologic Malignancy Reports, 2021, v. 16, n. 5, p. 418, doi. 10.1007/s11899-021-00644-2

By:

Ahmed, Aadil;
Mirza, Kamran M.;
Loghavi, Sanam

Publication type:

Article

BTK Inhibitors in Chronic Lymphocytic Leukemia.

Published in:

Current Hematologic Malignancy Reports, 2021, v. 16, n. 5, p. 422, doi. 10.1007/s11899-021-00645-1

By:

Gaballa, Sameh;
Pinilla-Ibarz, Javier

Publication type:

Article

Avapritinib in the Treatment of Systemic Mastocytosis: an Update.

Published in:

Current Hematologic Malignancy Reports, 2021, v. 16, n. 5, p. 464, doi. 10.1007/s11899-021-00650-4

By:

Below, Samantha;
Michaelis, Laura C.

Publication type:

Article

Philadelphia-Negative Myeloproliferative Neoplasms Around the COVID-19 Pandemic.

Published in:

Current Hematologic Malignancy Reports, 2021, v. 16, n. 5, p. 455, doi. 10.1007/s11899-021-00647-z

By:

Barbui, Tiziano;
De Stefano, Valerio

Publication type:

Article

Challenges in Chronic Myeloid Leukemia Management in South America.

Published in:

Current Hematologic Malignancy Reports, 2021, v. 16, n. 5, p. 440, doi. 10.1007/s11899-021-00654-0

By:

Pagnano, Katia B.;
Varela, Ana Ines;
Pavlovsky, Carolina;
Bendit, Israel;
Funke, Vaneuza A. M.;
Polo, Virginia Abello

Publication type:

Article

The Evolving Landscape of Frontline Therapy in Chronic Phase Chronic Myeloid Leukemia (CML).

Published in:

Current Hematologic Malignancy Reports, 2021, v. 16, n. 5, p. 448, doi. 10.1007/s11899-021-00655-z

By:

Wolfe, Heather R.;
Rein, Lindsay A. M.

Publication type:

Article

Treatment-Free Remission: the New Goal in CML Therapy.

Published in:

Current Hematologic Malignancy Reports, 2021, v. 16, n. 5, p. 433, doi. 10.1007/s11899-021-00653-1

By:

Atallah, Ehab;
Sweet, Kendra

Publication type:

Article

Management of Myelofibrosis-Associated Anemia: Focus on Standard Agents and Novel Therapeutics in Phase 3 Clinical Trials.

Published in:

Current Hematologic Malignancy Reports, 2021, v. 16, n. 5, p. 483, doi. 10.1007/s11899-021-00651-3

By:

Stein, Brady L.

Publication type:

Article

Management and Outcomes of Blast Transformed Chronic Myelomonocytic Leukemia.

Published in:

Current Hematologic Malignancy Reports, 2021, v. 16, n. 5, p. 405, doi. 10.1007/s11899-021-00643-3

By:

Hammond, Danielle;
Montalban-Bravo, Guillermo

Publication type:

Article

Application of Next-Generation Sequencing-Based Mutational Profiling in Acute Lymphoblastic Leukemia.

Published in:

Current Hematologic Malignancy Reports, 2021, v. 16, n. 5, p. 394, doi. 10.1007/s11899-021-00641-5

By:

Aleem, Ahmed;
Haque, Ali R.;
Roloff, Gregory W.;
Griffiths, Elizabeth A.

Publication type:

Article

Management Issues and Controversies in Low-Risk Patients with Essential Thrombocythemia and Polycythemia Vera.

Published in:

Current Hematologic Malignancy Reports, 2021, v. 16, n. 5, p. 473, doi. 10.1007/s11899-021-00649-x

By:

How, Joan;
Hobbs, Gabriela

Publication type:

Article

Acute Lymphoblastic Leukemia and Acute Lymphoblastic Lymphoma: Same Disease Spectrum but Two Distinct Diagnoses.

Published in:

Current Hematologic Malignancy Reports, 2021, v. 16, n. 5, p. 384, doi. 10.1007/s11899-021-00648-y

By:

Kline, Kathryn A. F.;
Kallen, Michael E.;
Duong, Vu H.;
Law, Jennie Y.

Publication type:

Article

Targeting BCMA in Multiple Myeloma.

Published in:

Current Hematologic Malignancy Reports, 2021, v. 16, n. 5, p. 367, doi. 10.1007/s11899-021-00639-z

By:

Tan, Carlyn Rose;
Shah, Urvi A.

Publication type:

Article